<?xml version="1.0" encoding="UTF-8"?>
<ref id="B61-vaccines-07-00074">
 <label>61.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Stefic</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Bouvin-Pley</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Essat</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Visdeloup</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Moreau</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Goujard</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Chaix</surname>
    <given-names>M.-L.</given-names>
   </name>
   <name>
    <surname>Braibant</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Meyer</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Barin</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time</article-title>
  <source>J. Virol.</source>
  <year>2019</year>
  <volume>93</volume>
  <fpage>e01492-18</fpage>
  <pub-id pub-id-type="doi">10.1128/JVI.01492-18</pub-id>
  <pub-id pub-id-type="pmid">30404804</pub-id>
 </element-citation>
</ref>
